Literature DB >> 26775555

Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function.

Raelene E Maser1, M James Lenhard2, Ryan T Pohlig3, P Babu Balagopal4.   

Abstract

AIMS: Osteopontin (OPN) and osteoprotegerin (OPG) are bone metabolism biomarkers potentially associated with nerve function. We evaluated the association of cardiovascular autonomic nerve function, OPN, and OPG in 50 individuals with type 2 diabetes mellitus (T2DM).
METHODS: RR-variation during deep breathing (i.e., mean circular resultant (MCR) and expiration/inspiration (E/I) ratio) was used to assess parasympathetic nerve function. Participants' demographics, HbA1c, 25-hydroxyvitamin D (25(OH)D), BMI, HOMA-IR, calcium, parathyroid hormone, creatinine, OPN, and OPG were determined.
RESULTS: Using stepwise multiple linear regression analysis with MCR or E/I ratio as the dependent variable, OPN was independently associated with reduced autonomic function. A previous report showed a significant association of cardiovascular autonomic function with age, 25(OH)D insufficiency, and the interaction of age×25(OH)D insufficiency. Here we report a novel association for OPN and its interaction with age indicating that for those who are younger, elevated OPN levels are related to a greater loss of autonomic function (MCR model R2=0.598, p<0.001; E/I model R2=0.594, p<0.001).
CONCLUSION: Our results suggest that OPN is associated with reduced parasympathetic function, particularly in younger individuals with T2DM. Further studies are needed to determine if OPN is neuroprotective, involved in the pathogenesis of autonomic dysfunction, or a bystander.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular autonomic nerve function; Osteopontin; Osteoprotegerin; Parasympathetic nerve function; Type 2 diabetes mellitus

Mesh:

Substances:

Year:  2015        PMID: 26775555      PMCID: PMC5646274          DOI: 10.1016/j.jdiacomp.2015.12.012

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  25 in total

Review 1.  Apoptosis: a key in neurodegenerative disorders.

Authors:  Oleksandr Ekshyyan; Tak Yee Aw
Journal:  Curr Neurovasc Res       Date:  2004-10       Impact factor: 1.990

2.  Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin.

Authors:  T Wada; M D McKee; S Steitz; C M Giachelli
Journal:  Circ Res       Date:  1999-02-05       Impact factor: 17.367

3.  Osteocalcin- and osteopontin-containing neurons in the rat hind brain.

Authors:  Toshihiko Suzuki; Tadasu Sato; Hiroyuki Ichikawa
Journal:  Cell Mol Neurobiol       Date:  2012-05-03       Impact factor: 5.046

Review 4.  Cardiac autonomic neuropathy in patients with diabetes mellitus.

Authors:  Gerasimos Dimitropoulos; Abd A Tahrani; Martin J Stevens
Journal:  World J Diabetes       Date:  2014-02-15

5.  Plasma osteopontin levels and expression in adipose tissue are increased in obesity.

Authors:  Javier Gómez-Ambrosi; Victoria Catalán; Beatriz Ramírez; Amaia Rodríguez; Inmaculada Colina; Camilo Silva; Fernando Rotellar; Carmen Mugueta; María J Gil; Javier A Cienfuegos; Javier Salvador; Gema Frühbeck
Journal:  J Clin Endocrinol Metab       Date:  2007-06-26       Impact factor: 5.958

6.  Below-knee arterial calcification in type 2 diabetes: association with receptor activator of nuclear factor κB ligand, osteoprotegerin, and neuropathy.

Authors:  Olivier Bourron; Carole Elodie Aubert; Sophie Liabeuf; Philippe Cluzel; Frédérique Lajat-Kiss; Michel Dadon; Michel Komajda; Romuald Mentaverri; Michel Brazier; Antoine Pierucci; Florence Morel; Sophie Jacqueminet; Ziad A Massy; Agnès Hartemann
Journal:  J Clin Endocrinol Metab       Date:  2014-07-11       Impact factor: 5.958

7.  Osteoprotegerin is independently associated with metabolic syndrome and microvascular complications in type 2 diabetes mellitus.

Authors:  S Tavintharan; Li Ting Sharon Pek; Jian Jun Liu; Xiao Wei Ng; Lee Ying Yeoh; Lim Su Chi; Sum Chee Fang
Journal:  Diab Vasc Dis Res       Date:  2014-07-07       Impact factor: 3.291

8.  Novel roles for osteopontin and clusterin in peripheral motor and sensory axon regeneration.

Authors:  Megan C Wright; Ruifa Mi; Emmalynn Connor; Nicole Reed; Alka Vyas; Manula Alspalter; Giovanni Coppola; Daniel H Geschwind; Thomas M Brushart; Ahmet Höke
Journal:  J Neurosci       Date:  2014-01-29       Impact factor: 6.167

9.  OSTEOPONTIN: A KEY LINK BETWEEN IMMUNITY, INFLAMMATION AND THE CENTRAL NERVOUS SYSTEM.

Authors:  Amanda Brown
Journal:  Transl Neurosci       Date:  2012-02-01       Impact factor: 1.757

10.  Effect of treatment with losartan on cardiovascular autonomic and large sensory nerve fiber function in individuals with diabetes mellitus: a 1-year randomized, controlled trial.

Authors:  Raelene E Maser; M James Lenhard
Journal:  J Diabetes Complications       Date:  2003 Sep-Oct       Impact factor: 2.852

View more
  6 in total

1.  Osteopontin and clusterin levels in type 2 diabetes mellitus: differential association with peripheral autonomic nerve function.

Authors:  Raelene E Maser; M James Lenhard; Ryan T Pohlig; P Babu Balagopal
Journal:  Neurol Sci       Date:  2017-06-21       Impact factor: 3.307

2.  Determinant of Osteopontin Levels in Microvascular Complications in Patients with Diabetes.

Authors:  Shaik Sarfaraz Nawaz; Khalid Siddiqui; Muhammad Mujammami; Obeed Alotaibi; Saud Sulaiman Alanazi; Mohamed Rafiullah
Journal:  Int J Gen Med       Date:  2022-04-27

3.  Pre-heparin lipoprotein lipase mass as a potential mediator in the association between adiponectin and HDL-cholesterol in type 2 diabetes.

Authors:  Raelene E Maser; M James Lenhard; Ryan T Pohlig; P Babu Balagopal
Journal:  J Clin Transl Endocrinol       Date:  2016-12-10

4.  MicroRNA-29a-3p enhances dental implant osseointegration of hyperlipidemic rats via suppressing dishevelled 2 and frizzled 4.

Authors:  Fei Liu; Zhifeng Wang; Fangfang Liu; Jinzhao Xu; Qibo Liu; Kaifeng Yin; Jing Lan
Journal:  Cell Biosci       Date:  2018-10-26       Impact factor: 7.133

5.  Increased osteoprotegerin level is associated with impaired cardiovagal modulation in type-2 diabetic patients treated with oral antidiabetic drugs.

Authors:  M R Jasmine; Nivedita Nanda; Jayaprakash Sahoo; S Velkumary; G K Pal
Journal:  BMC Cardiovasc Disord       Date:  2020-10-20       Impact factor: 2.298

6.  Relationship between saline infusion and blood pressure variability in non-critically patients with hypertension: A retrospective study.

Authors:  Jianhua Wu; Junjie Nie; Yue Wang; Yingpei Zhang; Dongfang Wu
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.